It has been demonstrated in several studies that PI3K/AKT pathway is activated in a variety of cancers in humans, while inhibiting the activity of PI3K/AKT pathway suppresses the proliferation of tumor cells, and it has been investigated in several clinical trials [21]. The gene discussed is AKT1; the disease is cancer.